GMED
Globus Medical
Globus Medical historical holders
total: 2
Muhlenkamp & Co Globus Medical transactions over time
- Total transactions:
- 5
- New positions:
- 1
- Sold out:
- 1
- Added:
- 1
- Reduced:
- 2
- Held since:
- 2013 Q2 or earlier
- Held for:
- 4+ quarters
- Latest activity:
- 2014 Q2
Ronald Muhlenkamp has been an institutional investor in Globus Medical (GMED) since at least 2013 Q2. According to 2026 Q1 report, Ronald Muhlenkamp doesn't hold any shares. In our earliest available record from 2013 Q2, Muhlenkamp & Co held 96,150 shares of GMED. Since at least 2013 Q2, Muhlenkamp & Co has made 4 more transactions in this position.
When did Ronald Muhlenkamp exit their GMED position?
Ronald Muhlenkamp no longer holds Globus Medical (GMED). They sold off their entire position in 2014 Q2, closing out an investment that began in 2013 Q2.
Estimated cost basis*
- Weighted AVG buy price:
- $17.41
- Weighted AVG sell price:
- $26.41
GMED transactions history by Muhlenkamp & Co
5 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2014 Q2
|
0.00%
|
$26.59
|
-100% (-51,480)
|
|||
|
2014 Q1
|
0.24%
|
$26.59
|
-54.39% (-61,395)
|
|||
|
2013 Q4
|
0.40%
|
$20.18
|
+20.33% (+19,070)
|
|||
|
2013 Q3
|
0.33%
|
$17.46
|
-2.44% (-2,345)
|
|||
|
2013 Q2
|
0.34%
|
$16.86
|
new or own*
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.